Logo image
Se connecter
Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group
Article de revue   Avec comité de lecture

Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group

Yann Guillermin, Charles Herbaux, Fabien Subtil, Thérèse Aurran-Schleinitz, Florence Cymbalista, Remi Letestu, Stéphane Leprêtre, Sandrine Vaudaux, Kamel Laribi, Véronique Leblond, …
American journal of hematology, Vol.93(1), pp.E24-E27
01/2018
PMID: 29055105

Résumé

Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cyclophosphamide - therapeutic use Follow-Up Studies Humans Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Remission Induction Retrospective Studies Vidarabine - analogs & derivatives Vidarabine - therapeutic use

Indicateurs

1 Consultations de la notice

Détails

Logo image